Journal of Clinical Oncology, Vol 10, 356-363, Copyright © 1992 by American Society of Clinical Oncology

ARTICLES

Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma

DE Wazer, T DiPetrillo, R Schmidt-Ullrich, L Weld, TJ Smith, DJ Marchant and NJ Robert
Breast Health Center, New England Medical Center, Tufts University School of Medicine, Boston, MA.

PURPOSE: The study was undertaken to assess the relationship among cosmesis and complications to factors related to disease presentation, surgical and radiotherapeutic technique, and adjuvant systemic therapy in conservative treatment for early-stage breast carcinoma. PATIENTS AND METHODS: Between 1982 and 1988, 234 women with stage I/II breast carcinoma were treated with conservation therapy by a highly standardized protocol of limited excision and radiotherapy. Radiation boost and/or reexcision were determined by careful quantitation of the normal tissue margin around the primary tumor. Boosts to 20 Gy were preferentially performed with interstitial iridium-192 (192Ir) implants. Axillary node dissections were performed in all patients aged less than 70 years. Adjuvant therapy consisted of cyclophosphamide, methotrexate, (doxorubicin), and fluorouracil (CM[A]F) six to eight times for node-positive premenopausal women and tamoxifen for node- positive or -negative postmenopausal women. Median follow-up was 50 months (range, 20 to 80 months). Cosmesis was graded by defined criteria, and complications were individually scored. RESULTS: Factors found to impact cosmesis adversely were palpable tumors (P = .046), volume of breast tissue resected (P = .027), reexcision of the tumor bed (P = .01), number of radiation fields (P = .03), radiation boost (P = .01), and chest wall separation (P = .01). There was a trend toward worse cosmesis (P = .062) in patients receiving tamoxifen. Cosmesis was not adversely affected by interstitial implant in spite of a higher prescribed dose. Factors influencing complication risk were axillary node dissection (P = .02), number of lymph nodes harvested (P = .05), and chemotherapy (P = .03). CONCLUSIONS: Optimal cosmesis and minimal complication risk require careful attention to the technical details of surgery and radiotherapy. The impact of systemic therapies needs to be more thoroughly examined.

This article has been cited by other articles:

				M. J. O'Sullivan, T. Li, G. Freedman, and M. Morrow The Effect of Multiple Reexcisions on the Risk of Local Recurrence After Breast Conserving Surgery Ann. Surg. Oncol., November 1, 2007; 14(11): 3133 - 3140. [Abstract] [Full Text] [PDF]

				R. L. Rahman, S. Crawford, A. Larkin, and R. Quinlan Superiority of Sonographic Hematoma Guided Resection of Mammogram Only Visible Breast Cancer: Wire Localization Should be an Exception Not the Rule Ann. Surg. Oncol., August 1, 2007; 14(8): 2228 - 2232. [Abstract] [Full Text] [PDF]

				N. Cabioglu, K. K. Hunt, A. A. Sahin, H. M. Kuerer, G. V. Babiera, S. E. Singletary, G. J. Whitman, M. I. Ross, F. C. Ames, B. W. Feig, et al. Role for Intraoperative Margin Assessment in Patients Undergoing Breast-Conserving Surgery Ann. Surg. Oncol., April 1, 2007; 14(4): 1458 - 1471. [Abstract] [Full Text] [PDF]

				M. C. van Rijk, P. J. Tanis, O. E. Nieweg, C. E. Loo, R. A. V. Olmos, H. S. A. Oldenburg, E. J. Th. Rutgers, C. A. Hoefnagel, and B. B. R. Kroon Sentinel Node Biopsy and Concomitant Probe-Guided Tumor Excision of Nonpalpable Breast Cancer Ann. Surg. Oncol., February 1, 2007; 14(2): 627 - 632. [Abstract] [Full Text] [PDF]

				V. S. Klimberg, J. Kepple, G. Shafirstein, L. Adkins, R. Henry-Tillman, E. Youssef, J. Brito, L. Talley, and S. Korourian eRFA: Excision Followed by RFA--a New Technique to Improve Local Control in Breast Cancer Ann. Surg. Oncol., November 1, 2006; 13(11): 1422 - 1433. [Abstract] [Full Text] [PDF]

				A. P. S. van der Velden, P. H. M. Peeters, V. C. M. Koot, and A. Hennipman Local Recurrences After Conservative Treatment of Ductal Carcinoma-In-Situ of the Breast Without Radiotherapy: The Effect of Age Ann. Surg. Oncol., July 1, 2006; 13(7): 990 - 998. [Abstract] [Full Text] [PDF]

				D. Azria, A. Pelegrin, J.-B. Dubois, R.-O. Mirimanoff, and M. Ozsahin Radiation Therapy and Tamoxifen: Concurrent or Sequential? It's No Longer the Question! J. Clin. Oncol., June 20, 2005; 23(18): 4239 - 4241. [Full Text] [PDF]

				T. J. Whelan Use of Conventional Radiation Therapy As Part of Breast-Conserving Treatment J. Clin. Oncol., March 10, 2005; 23(8): 1718 - 1725. [Full Text] [PDF]

				D. W. Arthur and F. A. Vicini Accelerated Partial Breast Irradiation As a Part of Breast Conservation Therapy J. Clin. Oncol., March 10, 2005; 23(8): 1726 - 1735. [Full Text] [PDF]

				T. Whelan and M. Levine Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question J. Clin. Oncol., January 1, 2005; 23(1): 1 - 4. [Full Text] [PDF]

				L. J. Pierce, L. F. Hutchins, S. R. Green, D. L. Lew, J. R. Gralow, R. B. Livingston, C. K. Osborne, and K. S. Albain Sequencing of Tamoxifen and Radiotherapy After Breast-Conserving Surgery in Early-Stage Breast Cancer J. Clin. Oncol., January 1, 2005; 23(1): 24 - 29. [Abstract] [Full Text] [PDF]

				K. S. Hughes, L. A. Schnaper, D. Berry, C. Cirrincione, B. McCormick, B. Shank, J. Wheeler, L. A. Champion, T. J. Smith, B. L. Smith, et al. Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer N. Engl. J. Med., September 2, 2004; 351(10): 971 - 977. [Abstract] [Full Text] [PDF]

				F. Meric, T. A. Buchholz, N. Q. Mirza, G. Vlastos, F. C. Ames, M. I. Ross, R. E. Pollock, S. E. Singletary, B. W. Feig, H. M. Kuerer, et al. Long-Term Complications Associated With Breast-Conservation Surgery and Radiotherapy Ann. Surg. Oncol., July 1, 2002; 9(6): 543 - 549. [Abstract] [Full Text] [PDF]

				L. Liberman, S. L. Goodstine, D. D. Dershaw, E. A. Morris, L. R. LaTrenta, A. F. Abramson, and K. J. V. Zee One Operation After Percutaneous Diagnosis of Nonpalpable Breast Cancer: Frequency and Associated Factors Am. J. Roentgenol., March 1, 2002; 178(3): 673 - 679. [Abstract] [Full Text] [PDF]

				G. R. Gibson, B.-A. Lesnikoski, J. Yoo, L. A. Mott, B. Cady, and R. J. Barth Jr. A Comparison of Ink-Directed and Traditional Whole-Cavity Re-Excision for Breast Lumpectomy Specimens With Positive Margins Ann. Surg. Oncol., October 1, 2001; 8(9): 693 - 704. [Abstract] [Full Text] [PDF]

				S. A Norman, L. T Miller, H B. Erikson, M F. Norman, and R. McCorkle Development and Validation of a Telephone Questionnaire to Characterize Lymphedema in Women Treated for Breast Cancer Physical Therapy, June 1, 2001; 81(6): 1192 - 1205. [Abstract] [Full Text] [PDF]

				B. A. Kramer, D. W. Arthur, K. Ulin, R. K. A. Schmidt-Ullrich, R. D. Zwicker, and D. E. Wazer Cosmetic Outcome in Patients Receiving an Interstitial Implant as Part of Breast-Conservation Therapy Radiology, October 1, 1999; 213(1): 61 - 66. [Abstract] [Full Text]

				COSMETIC OUTCOMES OF CONSERVATIVE BREAST-CANCER THERAPY Journal Watch (General), April 21, 1992; 1992(421): 5 - 5. [Full Text]